# Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

> **NCT04339764** · PHASE1,PHASE2 · RECRUITING · sponsor: **National Eye Institute (NEI)** · enrollment: 20 (estimated)

## Conditions studied

- Dry Age-Related Macular Degeneration
- Geographic Atrophy

## Interventions

- **DRUG:** iPSC-derived RPE/PLGA transplantation

## Key facts

- **NCT ID:** NCT04339764
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-23
- **Primary completion:** 2029-05-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04339764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04339764, "Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04339764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*